1178. Interactive Panelist
Session: Interactive Session: Interactive Cases in Transplant ID
Saturday, October 5, 2013: 8:30 AM
Room: The Moscone Center: Esplanade Ballroom 301-310
Janice Brown, MD, Division of Blood and Marrow Transplant and Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, CA

1977 - 81 B.S. Biological Sciences, Stanford University, Stanford, CA
1981 - 82 M.S. Biological Sciences, Stanford University, Stanford, CA
1982 - 87 M.D., University of Virginia School of Medicine, VA
1987-90 Resident, Internal Medicine, Stanford University Hospital, Stanford, CA
1992-96 Fellow, Infectious Diseases, Stanford University Hospital Medical Center, Stanford, CA
1990-92 Clinical Instructor, Department of Medicine, Stanford University Medical Center, Stanford, CA
1996-99 Research Associate and Staff Physician, Division of Infectious Diseases, Division of Bone Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA
1999 - present Assistant Professor, Division of Bone Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA
1986 Omicron Delta Kappa; scholarship, University of Virginia School of Medicine
1986 Raven Society; scholarship
1986 Bowman Scholarship nominee; clinical excellence
1994 Trainee Investigator Award: American Federation for Clinical Research
2000 Best Abstract Award: American Society for Blood and Marrow transplantation
Brown JM. "Infectious Diseases (Chapters 54-64)" in: Medicine. MC Fishman, AR Hoffman, R Klausner, M Thaler. Philadelphia. Lippincott and company. 1996: 4th edition
Arber C, BitMansour A, Brown JM. Functional engraftment of myeloid progenitors with protection against lethal fungal infection is not MHC-restricted. (submitted JID May 2005)
Sharma A, BitMansour A, Moore JA, Brown JM. Single, high dose AmBisome as prophylaxis against invasive aspergillosis following hematopoietic cell transplantation
(submitted JID May 2005)
Dvorak CC, Steinbach WJ, Brown JMY, Agarwal R. Risks and Outcomes of Invasive Fungal Infections in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell
Transplantation (submitted Blood April 2005)
Bitmansour A, Cao TM, Chao S, Shashidhar S, Brown JM. Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. Blood. 2005 May 1;105(9):3535-7
Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG, Negrin RS, Chao NJ. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Jan;11(1):47-55
Brown JM, Weissman IL. Progress and prospects in hematopoietic stem cell expansion and transplantation. Exp Hematol. 2004 Aug;32(8):693-5
Brown JM. Fungal infections in bone marrow transplant patients. Curr Opin Infect Dis. 2004 Aug;17(4):347-52. Review
Arber C, BitMansour A , Higgins JP., Weissman IL., Shizuru JA, Brown JM. Common lymphoid progenitors rapidly engraft and protect against lethal murine CMV infection after syngeneic and allogeneic hematopoietic stem cell transplantation. Blood. 2003 Jul 15;102(2):421-8
BitMansour A, Brown JM. Prophylactic administration of liposomal amphotericin is superior to treatment in murine model of invasive aspergillosis following hematopoietic cell transplantation. J Infectious Diseases 2002 Jul 1;186(1):134-7
BitMansour A, Burns SM, Traver D, Akashi K, Contag CH, Weissman IL, Brown JM. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood 2002 Dec 15;100(13):4660-7

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.